Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Stilgenbauer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dalton Transactions (Cambridge, England : 2003)|April 29, 2020
Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworksIssiah B Lozada, Bin Huang, Morgan Stilgenbauer, et al.
Molecules (Basel, Switzerland)|July 14, 2023
Lipophilic Fe(III)-Complex with Potent Broad-Spectrum Anticancer Activity and Ability to Overcome Pt Resistance in A2780cis Cancer CellsNalin Abeydeera, Morgan Stilgenbauer, Bishnu D Pant, et al.
Bioconjugate Chemistry|January 21, 2021
Chemo-Mechanical Modulation of Cell Motions Using DNA NanospringsDeepak Karna, Morgan Stilgenbauer, Sagun Jonchhe, et al.
Dalton Transactions (Cambridge, England : 2003)|December 20, 2017
Nanoparticles of metal-organic cages designed to encapsulate platinum-based anticancer agentsZhizhou Yue, Han Wang, David J Bowers, et al.
Dalton Transactions (Cambridge, England : 2003)|June 4, 2020
Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in bloodPayel Datta, Scott Bang, Zhizhou Yue, et al.
Chemical Communications (Cambridge, England)|August 14, 2020
Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36Amarasooriya M D S Jayawardhana, Morgan Stilgenbauer, Payel Datta, et al.
Chemical Communications (Cambridge, England)|May 10, 2019
A spermine-conjugated lipophilic Pt(iv) prodrug designed to eliminate cancer stem cells in ovarian cancerMorgan Stilgenbauer, Amarasooriya M D S Jayawardhana, Payel Datta, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dalton Transactions (Cambridge, England : 2003)|April 29, 2020
Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworksIssiah B Lozada, Bin Huang, Morgan Stilgenbauer, et al.
Molecules (Basel, Switzerland)|July 14, 2023
Lipophilic Fe(III)-Complex with Potent Broad-Spectrum Anticancer Activity and Ability to Overcome Pt Resistance in A2780cis Cancer CellsNalin Abeydeera, Morgan Stilgenbauer, Bishnu D Pant, et al.
Bioconjugate Chemistry|January 21, 2021
Chemo-Mechanical Modulation of Cell Motions Using DNA NanospringsDeepak Karna, Morgan Stilgenbauer, Sagun Jonchhe, et al.
Dalton Transactions (Cambridge, England : 2003)|December 20, 2017
Nanoparticles of metal-organic cages designed to encapsulate platinum-based anticancer agentsZhizhou Yue, Han Wang, David J Bowers, et al.
Dalton Transactions (Cambridge, England : 2003)|June 4, 2020
Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in bloodPayel Datta, Scott Bang, Zhizhou Yue, et al.
Chemical Communications (Cambridge, England)|August 14, 2020
Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36Amarasooriya M D S Jayawardhana, Morgan Stilgenbauer, Payel Datta, et al.
Chemical Communications (Cambridge, England)|May 10, 2019
A spermine-conjugated lipophilic Pt(iv) prodrug designed to eliminate cancer stem cells in ovarian cancerMorgan Stilgenbauer, Amarasooriya M D S Jayawardhana, Payel Datta, et al.
Pageof 1